|
|
|
|
|
| Sustainability In Small Molecule API Manufacturing | White Paper | MilliporeSigma | Redesigning chemical processes with green chemistry principles can cut emissions, reduce waste, and improve efficiency. See how smarter synthesis and digital tools enable sustainable API manufacturing. |
|
|
|
|
|
|
By BioPhorum | Establishing a robust single-use systems (SUS) interchangeability program can be a pivotal feature of a supply chain resiliency initiative. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
|
| Considerations When Outsourcing Your Packaging Operations | Q&A | By Yves Massicotte, Ropack Pharma Solutions | Learn the key to maintaining and enhancing existing and new partnerships, as well as how outsourcing one crucial aspect of bringing products to market can benefit overall supply chain optimization. |
|
|
| Partnership Goals For Scale-Up Success | Article | By Jason Larocco, SMC Ltd. | As demand for capabilities and resources grows throughout a project, both become strained in-house and the scale-up process becomes a steeper hill to climb. |
|
|
|
|
| How To Fast-Track Your Oral Solid Dose To Phase 1 | Article | By Chukwuma Ude, Pace Life Sciences | A strategic approach accelerates oral solid dose development by uniting molecular analysis, solubility improvement, formulation design, manufacturing efficiency, and stability testing to reach Phase 1 faster. |
|
|
|
|
| Engineering Excellence In Container Closure Integrity Testing | Article | By Oliver Stauffer, PTI Packaging and Inspection Systems | Review the critical factors that define a reliable container closure integrity method, as well as what truly distinguishes robust, reproducible testing in today’s demanding parenteral landscape. |
|
|
|
| Hanson Wade-Nasal Formulation and Drug Delivery Summit | The 4th Nasal Formulation & Delivery Summit is uniting formulation, delivery, and product development leaders to advance the development of safe, effective, and commercially viable intranasal therapies. Join 70+ experts from Eli Lilly, Bayer, Neurelis, Virpax Pharmaceuticals, Belhaven Biopharma, and more to explore real-world preclinical and clinical data, compare liquid and powder nasal approaches, and align on best practices for systemic and nose-to-brain delivery. |
|
|
|
|
|
|
|
|
|
|
| Connect With Pharmaceutical Online: |
|
|
|